Baird Capital leads $12.8M Series B funding round for Houston health tech

Medical device company Saranas Inc. closed a $12.8 million Series B funding round, the firm announced July 19. The Series B round was led by Chicago-based Baird Capital, the venture capital and private equity arm of Milwaukee-based Robert W. Baird& Co. The round also saw participation from Austin, Texas-based S3 Ventures. Houston-based Saranas develops an FDA-approved medical device for early detection and monitoring of internal bleeding complications. Saranas' Early Bird device aims to improve…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news